DANNELLE PENROD: Open Payments
NPI 1831939081 · GLOUCESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 30 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $146 · 2025 $704
Food & beverage: $605Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $300 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $241 |
| ABBVIE INC. | 3 | $61 |
| Ardelyx, Inc. | 3 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: TREMFYA, ENTYVIO, IBSRELA, XIFAXAN, LINZESS, EOHILIA, SKYRIZI, VOQUEZNA.
Industry payments across VA — which companies pay providers there.
